Sequent Scientific Limited (NSE:SEQUENT)
168.61
-3.36 (-1.95%)
Aug 1, 2025, 3:30 PM IST
FARO Technologies Revenue
In the fiscal year ending March 31, 2025, Sequent Scientific had annual revenue of 15.51B INR with 13.26% growth. Sequent Scientific had revenue of 4.02B in the quarter ending March 31, 2025, with 11.21% growth.
Revenue
15.51B
Revenue Growth
+13.26%
P/S Ratio
2.71
Revenue / Employee
12.47M
Employees
1,244
Market Cap
42.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 15.51B | 1.82B | 13.26% |
Mar 31, 2024 | 13.70B | -511.78M | -3.60% |
Mar 31, 2023 | 14.21B | 80.93M | 0.57% |
Mar 31, 2022 | 14.13B | 512.01M | 3.76% |
Mar 31, 2021 | 13.62B | 1.82B | 15.47% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.09B |
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 128.90B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.86B |
Sequent Scientific News
- 2 months ago - Sequent Scientific Q4 Results: Revenue up 11% YoY to Rs 401 crore - Business Upturn
- 6 months ago - Sequent Scientific Ltd (BOM:512529) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - GuruFocus
- 6 months ago - Sequent Scientific Q3 FY25 results: Revenue up 18.7% YoY to Rs 390.8 crore, Net profit declines 58.5% YoY - Business Upturn
- 6 months ago - India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Benzinga
- 9 months ago - SeQuent Scientific consolidates ownership of subsidiaries in Sweden and Italy - Business Upturn
- 9 months ago - Q2 2025 SeQuent Scientific Ltd Earnings Call Transcript - GuruFocus